4.6 Article

Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide- responsive and - resistant glioblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors

Encouse B. Golden et al.

NEUROSURGICAL FOCUS (2015)

Article Biochemistry & Molecular Biology

Bex2 Controls Proliferation of Human Glioblastoma Cells Through NF-κB Signaling Pathway

Qingming Meng et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2014)

Review Oncology

Emerging insights into barriers to effective brain tumor therapeutics

Graeme E. Woodworth et al.

FRONTIERS IN ONCOLOGY (2014)

Article Oncology

Targeting FACT Complex Suppresses Mammary Tumorigenesis in Her2/neu Transgenic Mice

Igor E. Koman et al.

CANCER PREVENTION RESEARCH (2012)

Article Cell Biology

NF-kappa B controls growth of glioblastomas/astrocytomas

Denise Smith et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)

Article Biochemistry & Molecular Biology

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

M Hermisson et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Multidisciplinary Sciences

Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors

KV Gurova et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)